tobramycin has been researched along with Neonatal Sepsis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darlow, C; Das, S; Farrington, N; Greenberg, R; Hope, W; Hornik, C; Jimenez-Valverde, A; Johnson, A; McEntee, L; Schwartz, J; Unsworth, J | 1 |
1 other study(ies) available for tobramycin and Neonatal Sepsis
| Article | Year |
|---|---|
Pharmacodynamics of Meropenem and Tobramycin for Neonatal Meningoencephalitis: Novel Approaches to Facilitate the Development of New Agents to Address the Challenge of Antimicrobial Resistance.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Meningoencephalitis; Meropenem; Microbial Sensitivity Tests; Neonatal Sepsis; Pseudomonas aeruginosa; Rabbits; Tobramycin | 2022 |